Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Vous n'êtes pas connecté
Researchers at the National Institute of Biology are exploring new avenues for more effective treatment of glioblastoma, the most aggressive form of brain cancer. They have discovered different biomarkers that could be used as drug targets in the future. In Slovenia, approximately 100 patients ...
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and...
Researchers at the University of Notre Dame, USAm have developed a novel, automated device capable of diagnosing glioblastoma, a fast-growing and...
Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in...
Discover the role of biomarkers in diagnosing and managing Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis.
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
62% of patients currently receiving treatment for depression-amounting to a staggering 5.1 to 5.6 million individuals-could qualify for psilocybin...
A new report by University of Bristol researchers shows that access to genomic testing for brain tumor patients is unfair, with fewer than 5% of...